Oropharyngeal swabs increase the number of viral infections detected by 15%, compared to collection of a nasopharyngeal swab alone.
Highlights
The global Oropharyngeal Swabs for COVID-19 Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Oropharyngeal Swabs for COVID-19 Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oropharyngeal Swabs for COVID-19 Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Oropharyngeal Swabs for COVID-19 Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Oropharyngeal Swabs for COVID-19 Testing include Roche, 1 Drop Inc, SolGent Co, Abbott, PerkinElmer, Inc, Diagnostic Hybrids, Inc, Hologic, COPAN Diagnostics Inc and LabCorp, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oropharyngeal Swabs for COVID-19 Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oropharyngeal Swabs for COVID-19 Testing.
The Oropharyngeal Swabs for COVID-19 Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oropharyngeal Swabs for COVID-19 Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oropharyngeal Swabs for COVID-19 Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche
1 Drop Inc
SolGent Co
Abbott
PerkinElmer, Inc
Diagnostic Hybrids, Inc
Hologic
COPAN Diagnostics Inc
LabCorp
Quidel
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co
Segment by Type
Nylon Fibers
Polyurethane Foam
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oropharyngeal Swabs for COVID-19 Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nylon Fibers
1.2.3 Polyurethane Foam
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Perspective (2018-2029)
2.2 Oropharyngeal Swabs for COVID-19 Testing Growth Trends by Region
2.2.1 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oropharyngeal Swabs for COVID-19 Testing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Oropharyngeal Swabs for COVID-19 Testing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Dynamics
2.3.1 Oropharyngeal Swabs for COVID-19 Testing Industry Trends
2.3.2 Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Drivers
2.3.3 Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Challenges
2.3.4 Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oropharyngeal Swabs for COVID-19 Testing Players by Revenue
3.1.1 Global Top Oropharyngeal Swabs for COVID-19 Testing Players by Revenue (2018-2023)
3.1.2 Global Oropharyngeal Swabs for COVID-19 Testing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oropharyngeal Swabs for COVID-19 Testing Revenue
3.4 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Concentration Ratio
3.4.1 Global Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oropharyngeal Swabs for COVID-19 Testing Revenue in 2022
3.5 Oropharyngeal Swabs for COVID-19 Testing Key Players Head office and Area Served
3.6 Key Players Oropharyngeal Swabs for COVID-19 Testing Product Solution and Service
3.7 Date of Enter into Oropharyngeal Swabs for COVID-19 Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Oropharyngeal Swabs for COVID-19 Testing Breakdown Data by Type
4.1 Global Oropharyngeal Swabs for COVID-19 Testing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Oropharyngeal Swabs for COVID-19 Testing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Oropharyngeal Swabs for COVID-19 Testing Breakdown Data by Application
5.1 Global Oropharyngeal Swabs for COVID-19 Testing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Oropharyngeal Swabs for COVID-19 Testing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size (2018-2029)
6.2 North America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2018-2023)
6.4 North America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size (2018-2029)
7.2 Europe Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size (2018-2029)
9.2 Latin America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Oropharyngeal Swabs for COVID-19 Testing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Oropharyngeal Swabs for COVID-19 Testing Introduction
11.1.4 Roche Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 1 Drop Inc
11.2.1 1 Drop Inc Company Detail
11.2.2 1 Drop Inc Business Overview
11.2.3 1 Drop Inc Oropharyngeal Swabs for COVID-19 Testing Introduction
11.2.4 1 Drop Inc Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.2.5 1 Drop Inc Recent Development
11.3 SolGent Co
11.3.1 SolGent Co Company Detail
11.3.2 SolGent Co Business Overview
11.3.3 SolGent Co Oropharyngeal Swabs for COVID-19 Testing Introduction
11.3.4 SolGent Co Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.3.5 SolGent Co Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Oropharyngeal Swabs for COVID-19 Testing Introduction
11.4.4 Abbott Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 PerkinElmer, Inc
11.5.1 PerkinElmer, Inc Company Detail
11.5.2 PerkinElmer, Inc Business Overview
11.5.3 PerkinElmer, Inc Oropharyngeal Swabs for COVID-19 Testing Introduction
11.5.4 PerkinElmer, Inc Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.5.5 PerkinElmer, Inc Recent Development
11.6 Diagnostic Hybrids, Inc
11.6.1 Diagnostic Hybrids, Inc Company Detail
11.6.2 Diagnostic Hybrids, Inc Business Overview
11.6.3 Diagnostic Hybrids, Inc Oropharyngeal Swabs for COVID-19 Testing Introduction
11.6.4 Diagnostic Hybrids, Inc Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.6.5 Diagnostic Hybrids, Inc Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Oropharyngeal Swabs for COVID-19 Testing Introduction
11.7.4 Hologic Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.7.5 Hologic Recent Development
11.8 COPAN Diagnostics Inc
11.8.1 COPAN Diagnostics Inc Company Detail
11.8.2 COPAN Diagnostics Inc Business Overview
11.8.3 COPAN Diagnostics Inc Oropharyngeal Swabs for COVID-19 Testing Introduction
11.8.4 COPAN Diagnostics Inc Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.8.5 COPAN Diagnostics Inc Recent Development
11.9 LabCorp
11.9.1 LabCorp Company Detail
11.9.2 LabCorp Business Overview
11.9.3 LabCorp Oropharyngeal Swabs for COVID-19 Testing Introduction
11.9.4 LabCorp Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.9.5 LabCorp Recent Development
11.10 Quidel
11.10.1 Quidel Company Detail
11.10.2 Quidel Business Overview
11.10.3 Quidel Oropharyngeal Swabs for COVID-19 Testing Introduction
11.10.4 Quidel Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.10.5 Quidel Recent Development
11.11 BGI
11.11.1 BGI Company Detail
11.11.2 BGI Business Overview
11.11.3 BGI Oropharyngeal Swabs for COVID-19 Testing Introduction
11.11.4 BGI Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.11.5 BGI Recent Development
11.12 Sansure
11.12.1 Sansure Company Detail
11.12.2 Sansure Business Overview
11.12.3 Sansure Oropharyngeal Swabs for COVID-19 Testing Introduction
11.12.4 Sansure Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.12.5 Sansure Recent Development
11.13 Liferiver Bio-Tech
11.13.1 Liferiver Bio-Tech Company Detail
11.13.2 Liferiver Bio-Tech Business Overview
11.13.3 Liferiver Bio-Tech Oropharyngeal Swabs for COVID-19 Testing Introduction
11.13.4 Liferiver Bio-Tech Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.13.5 Liferiver Bio-Tech Recent Development
11.14 Zhuhai Livzon Diagnostics Inc
11.14.1 Zhuhai Livzon Diagnostics Inc Company Detail
11.14.2 Zhuhai Livzon Diagnostics Inc Business Overview
11.14.3 Zhuhai Livzon Diagnostics Inc Oropharyngeal Swabs for COVID-19 Testing Introduction
11.14.4 Zhuhai Livzon Diagnostics Inc Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.14.5 Zhuhai Livzon Diagnostics Inc Recent Development
11.15 Vazyme
11.15.1 Vazyme Company Detail
11.15.2 Vazyme Business Overview
11.15.3 Vazyme Oropharyngeal Swabs for COVID-19 Testing Introduction
11.15.4 Vazyme Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.15.5 Vazyme Recent Development
11.16 Geneodx
11.16.1 Geneodx Company Detail
11.16.2 Geneodx Business Overview
11.16.3 Geneodx Oropharyngeal Swabs for COVID-19 Testing Introduction
11.16.4 Geneodx Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.16.5 Geneodx Recent Development
11.17 Wondfo
11.17.1 Wondfo Company Detail
11.17.2 Wondfo Business Overview
11.17.3 Wondfo Oropharyngeal Swabs for COVID-19 Testing Introduction
11.17.4 Wondfo Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.17.5 Wondfo Recent Development
11.18 Maccura Biotechnology Co
11.18.1 Maccura Biotechnology Co Company Detail
11.18.2 Maccura Biotechnology Co Business Overview
11.18.3 Maccura Biotechnology Co Oropharyngeal Swabs for COVID-19 Testing Introduction
11.18.4 Maccura Biotechnology Co Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.18.5 Maccura Biotechnology Co Recent Development
11.19 Wuhan Easy Diagnosis Biomedicine Co
11.19.1 Wuhan Easy Diagnosis Biomedicine Co Company Detail
11.19.2 Wuhan Easy Diagnosis Biomedicine Co Business Overview
11.19.3 Wuhan Easy Diagnosis Biomedicine Co Oropharyngeal Swabs for COVID-19 Testing Introduction
11.19.4 Wuhan Easy Diagnosis Biomedicine Co Revenue in Oropharyngeal Swabs for COVID-19 Testing Business (2018-2023)
11.19.5 Wuhan Easy Diagnosis Biomedicine Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
1 Drop Inc
SolGent Co
Abbott
PerkinElmer, Inc
Diagnostic Hybrids, Inc
Hologic
COPAN Diagnostics Inc
LabCorp
Quidel
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co
听
听
*If Applicable.
